We are dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.
Hampton, NJ
Joined December 2021
- Tweets124
- Following65
- Followers195
- Likes2
We are dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.